ResearcherChinese PLA General HospitalActive in the last 2 years

Boyu Qin

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5113261312. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper

Papers 2

Synergistic effect of additional anlotinib and immunotherapy as second-line or later-line treatment in pancreatic cancer: A retrospective cohort study. Co-author DOI 10.1002/cai2.123 ↗
Lactate Dehydrogenase B Is Required for Pancreatic Cancer Cell Immortalization Through Activation of Telomerase Activity. Co-author DOI 10.3389/fonc.2022.821620 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jing Zhang · 1 shared paper, 2024 · strength 0.19
- Paper Synergistic effect of additional anlotinib and immunotherapy as second-line or later-line treatment in pancreatic cance… DOI 10.1002/cai2.123 ↗
Bo Yeun Yang · 1 shared paper, 2024 · strength 0.19
- Paper Synergistic effect of additional anlotinib and immunotherapy as second-line or later-line treatment in pancreatic cance… DOI 10.1002/cai2.123 ↗
Ke Li · 1 shared paper, 2024 · strength 0.19
- Paper Synergistic effect of additional anlotinib and immunotherapy as second-line or later-line treatment in pancreatic cance… DOI 10.1002/cai2.123 ↗
Long Cheng · 1 shared paper, 2022 · strength 0.14
- Paper Lactate Dehydrogenase B Is Required for Pancreatic Cancer Cell Immortalization Through Activation of Telomerase Activit… DOI 10.3389/fonc.2022.821620 ↗
Ruiguan Wang · 1 shared paper, 2022 · strength 0.14
- Paper Lactate Dehydrogenase B Is Required for Pancreatic Cancer Cell Immortalization Through Activation of Telomerase Activit… DOI 10.3389/fonc.2022.821620 ↗
Rong Liu · 1 shared paper, 2022 · strength 0.14
- Paper Lactate Dehydrogenase B Is Required for Pancreatic Cancer Cell Immortalization Through Activation of Telomerase Activit… DOI 10.3389/fonc.2022.821620 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.